Brain Scientific reports use of EEG tools by neuromarketing company

Brain Scientific announced Friday that the neuro-marketing company Marketing Brainology has adopted its NeuroCap, a disposable EEG headset, as well as its NeuroEEG, a 16-channel portable EEG amplifier for use in research.

These electroencephalogram (EEG) tools are tests used to find problems related to electrical activity of the brain.

NeuroCap, manufactured by Brain Scientific’s subsidiary MemoryMD, is a disposable EEG headset with 22 electrodes and 19 EEG channels, which is now being put to the test in nursing homes, intensive care units and neurology clinics. The device provides high-quality EEG tracing within minutes.

READ: Brain Scientific says Super Bowl ad study finds Microsoft scored with its Xbox ‘We All Win’ spot

NeuroEEG, meanwhile, works in parallel with the NeuroCap. It’s a compact, portable and wireless EEG device that fits in the palm of the hand and is used to record, transmit and display electrical brain activity.

Plano, Texas-based Marketing Brainology adopted these two medical-grade EEG devices to accurately measure emotional responses to marketing content. The firm, for example, recently used Brain Scientific’s tools to evaluate television watchers’ emotional engagement with Super Bowl advertisements.

In its efforts to zero in on the science of human-decision making, the Texas company previously used a 64-channel EEG system that was bulky, difficult to operate and expensive for its research.

And Michelle Adams, founder and president of Marketing Brainology is glad to have made the change to BrainScientific’s more modern EEG tools.

“The [16-channel device] is still more than we need, but not overdoing it,” said Adams in a statement.

“Anyone who is used to the old technology would be in heaven with the MemoryMD product,” she added.

Brain Scientific, based in New York and Silicon Valley, develops high-tech neurological diagnostic devices used in telemedicine. It acquired its wholly-owned subsidiary MemoryMD last September.

Contact Ellen Kelleher at [email protected]

Story by ProactiveInvestors